mescaline has been researched along with Behavior Disorders in 44 studies
Mescaline: Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.
mescaline : A phenethylamine alkaloid that is phenethylamine substituted at positions 3, 4 and 5 by methoxy groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mescaline is a naturally occurring psychoactive phenethylamine found in several cacti and historically used ceremonially by Indigenous and Latin American populations." | 1.72 | The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. ( Davis, AK; Davis, D; Dolan, SB; Haas, TF; Lancelotta, R; Ramaekers, JG; Timmermann, C; Uthaug, MV, 2022) |
| "D-lysergic acid diethylamide (LSD) displays (1) the phenylethylamine pattern present in mescaline, cyclazocine and catecholamines and (2) the 4-substituted tryptamine structure of psilocybin which is a serotonin analog." | 1.25 | Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure. ( Fischer, R; Goldman, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (86.36) | 18.7374 |
| 1990's | 1 (2.27) | 18.2507 |
| 2000's | 3 (6.82) | 29.6817 |
| 2010's | 1 (2.27) | 24.3611 |
| 2020's | 1 (2.27) | 2.80 |
| Authors | Studies |
|---|---|
| Uthaug, MV | 1 |
| Davis, AK | 1 |
| Haas, TF | 1 |
| Davis, D | 1 |
| Dolan, SB | 1 |
| Lancelotta, R | 1 |
| Timmermann, C | 1 |
| Ramaekers, JG | 1 |
| Krebs, TS | 1 |
| Johansen, PØ | 1 |
| Csordas, TJ | 1 |
| Storck, MJ | 1 |
| Strauss, M | 1 |
| TEIRICH, H | 1 |
| DENBER, HC | 7 |
| MERLIS, S | 2 |
| SANGUINETI, I | 3 |
| NEGRI, VU | 1 |
| LARICCHIA, R | 3 |
| POSTEL, J | 1 |
| COSSA, P | 1 |
| DELAY, J | 1 |
| DENIKER, P | 1 |
| RACLOT, M | 1 |
| ROPERT, M | 1 |
| ZAPPAROLI, GC | 2 |
| SALERNO, EV | 1 |
| TALLAFERRO, A | 1 |
| STEVENSON, I | 3 |
| SANCHEZ, AJ | 1 |
| TONINI, G | 3 |
| HOCH, PH | 2 |
| MOKRASCH, LC | 2 |
| VAN WEST, A | 1 |
| VOJTECHOVSKY, M | 1 |
| GROF, S | 1 |
| COLE, JO | 1 |
| KATZ, MM | 1 |
| TOLAN, EJ | 1 |
| LINGL, FA | 1 |
| SHULGIN, AT | 1 |
| LEUNER, H | 1 |
| HAYMAN, M | 1 |
| FABING, HD | 1 |
| MISSERE, G | 1 |
| RICHARDS, TW | 1 |
| STEVENSON, IP | 1 |
| Sessa, B | 1 |
| Fickenscher, A | 1 |
| Novins, DK | 1 |
| Manson, SM | 1 |
| Turns, D | 1 |
| Moriarty, KM | 1 |
| Alagna, SW | 1 |
| Lake, CR | 1 |
| Hermle, L | 1 |
| Gouzoulis-Mayfrank, E | 1 |
| Spitzer, M | 1 |
| Abramson, HA | 1 |
| Gettner, HH | 1 |
| Fischer, R | 1 |
| Goldman, H | 1 |
| Naditch, MP | 1 |
| Schuster, E | 1 |
| Salzman, C | 1 |
| Lieff, J | 1 |
| Kochansky, GE | 1 |
| Shader, RI | 1 |
| Schoenfeld, LS | 1 |
| Miller, SI | 1 |
| Pintilie, C | 1 |
| Mison-Crighel, N | 1 |
| Crighel, E | 1 |
| Bergman, RL | 1 |
| Malitz, S | 1 |
3 reviews available for mescaline and Behavior Disorders
| Article | Year |
|---|---|
Psychopharmacology. An historical perspective.
Topics: Basidiomycota; Ceremonial Behavior; Cocaine; Hallucinogens; History, 20th Century; Humans; Illicit D | 1984 |
Double bonds, aliphatic chains, and hallucinogens, updated.
Topics: Animals; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Mice; N,N-D | 1979 |
[Pharmacology of psychodysleptic drugs. Research on the mechanism of action of mescaline].
Topics: Animals; Brain; Humans; Mental Disorders; Mescaline | 1969 |
1 trial available for mescaline and Behavior Disorders
| Article | Year |
|---|---|
[Hallucinogen induced psychic disorders. Subjective experiences, psychopathology and differential diagnosis].
Topics: Adolescent; Adult; Comorbidity; Female; Hallucinogens; Humans; Male; Mental Disorders; Mescaline; Mi | 1996 |
40 other studies available for mescaline and Behavior Disorders
| Article | Year |
|---|---|
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.
Topics: Adult; Hallucinogens; Humans; Mental Disorders; Mescaline; Motivation; Surveys and Questionnaires | 2022 |
Psychedelics and mental health: a population study.
Topics: Adolescent; Adult; Data Collection; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; | 2013 |
Diagnosis and distress in Navajo healing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcoholism; Anxiety Disorders; Ceremonial Behavior; Chri | 2008 |
[Injurious effects of mescaline].
Topics: Alkaloids; Humans; Mental Disorders; Mescaline; Psychoses, Substance-Induced; Psychotic Disorders | 1954 |
A note on some therapeutic implications of the mescaline-induced state.
Topics: Chlorpromazine; Humans; Mental Disorders; Mescaline; Phenethylamines; Psychotherapy | 1954 |
[Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
Topics: Brain; Electroconvulsive Therapy; Ergot Alkaloids; Lysergic Acid; Lysergic Acid Diethylamide; Mental | 1955 |
Studies on mescaline. VI. Therapeutic aspects of the mescaline-chlorpromazine combination.
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Mescaline; Phenethylamines; Psy | 1955 |
[Treatment by induced psychosis (mescaline and chlorpromazine)].
Topics: Chlorpromazine; Mental Disorders; Mescaline; Phenethylamines; Psychotic Disorders; Schizophrenia; Sh | 1956 |
[Mescaline in mental patients; clinical verifications].
Topics: Electroconvulsive Therapy; Mental Disorders; Mentally Ill Persons; Mescaline; Phenethylamines; Psych | 1956 |
Chlorpromazine and mescaline.
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Mescaline; Psychosurgery; Psych | 1956 |
Chlorpromazine and mescaline.
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Mescaline; Psychosurgery; Psych | 1956 |
Chlorpromazine and mescaline.
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Mescaline; Psychosurgery; Psych | 1956 |
Chlorpromazine and mescaline.
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Mescaline; Psychosurgery; Psych | 1956 |
[Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders].
Topics: Electroconvulsive Therapy; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Mental Disorders; Mesc | 1956 |
[Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders].
Topics: Electroconvulsive Therapy; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Mental Disorders; Mesc | 1956 |
[Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders].
Topics: Electroconvulsive Therapy; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Mental Disorders; Mesc | 1956 |
[Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders].
Topics: Electroconvulsive Therapy; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Mental Disorders; Mesc | 1956 |
[Mescaline, lysergic acid diethylamide (LSD 25) & menstruation].
Topics: Female; Humans; Lysergic Acid Diethylamide; Menstruation; Menstruation Disturbances; Mental Disorder | 1957 |
The antidotal action of sodium succinate in the mescaline psychosis.
Topics: Central Nervous System Stimulants; Humans; Mental Disorders; Mescaline; Psychotic Disorders; Sodium; | 1957 |
[Lysergic acid amides & mescaline in psychodiagnosis & psychotherapy].
Topics: Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychotherapy | 1957 |
[Importance of psychopathological factors & drug dosage in experimental psychoses].
Topics: Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychopathology; Psychotic Disorders | 1957 |
Psychoses-producing and psychoses-relieving drugs.
Topics: Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychotic Disorders | 1958 |
A further note on the mechanism of the antidotal action of sodium succinate in the mescaline psychosis.
Topics: Central Nervous System Stimulants; Humans; Mental Disorders; Mescaline; Psychoses, Substance-Induced | 1958 |
Studies on mescaline. X. Psychological changes before and after mescaline as measured by the M. M. P. I.
Topics: Humans; Mental Disorders; Mescaline; Personality; Personality Disorders; Psychological Tests | 1958 |
[Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
Topics: Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychotic Disorders | 1960 |
THE PSYCHOTOMIMETIC DRUGS. AN OVERVIEW.
Topics: Alcoholism; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychoph | 1964 |
"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.
Topics: Adolescent; Gasoline; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Diso | 1964 |
3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT.
Topics: Amphetamine; Amphetamines; Dogs; Hallucinogens; Mental Disorders; Mescaline; Mice; Oils; Oils, Volat | 1964 |
[FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Neurotic Disorders; Psilocyb | 1963 |
SCIENCE, MYSTICISM AND PSYCHOPHARMACOLOGY.
Topics: Humans; Mental Disorders; Mescaline; Mysticism; Psychiatry; Psychopharmacology; Regression, Psycholo | 1964 |
Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
Topics: Central Nervous System Stimulants; Ergot Alkaloids; Humans; Lysergic Acid Diethylamide; Mental Disor | 1955 |
[Experimental contribution to the problem of possible crossed tolerance between psychotic drugs of different structure].
Topics: Central Nervous System; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Nervous Sys | 1959 |
The metabolism of mescaline with a note on correlations between metabolism and psychological effects.
Topics: Humans; Mental Disorders; Mescaline | 1959 |
Consistency in the psychologic reaction to mescaline.
Topics: Counseling; Humans; Mental Disorders; Mercury; Mescaline; Psychotherapy | 1961 |
Experimentally produced abnormal mental states.
Topics: Humans; Mental Disorders; Mescaline; Schizophrenia | 1951 |
Can psychedelics have a role in psychiatry once again?
Topics: Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescalin | 2005 |
Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation.
Topics: Adolescent; Art Therapy; Behavior Therapy; Comorbidity; Counseling; Demography; Female; Humans; Illi | 2006 |
[Mescaline and psychotherapy].
Topics: Adult; Alcoholism; Female; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychoth | 1966 |
Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.
Topics: Binding Sites; Brain; Catecholamines; Chemical Phenomena; Chemistry; Hallucinogens; Humans; Lysergic | 1975 |
Acute adverse reactions to psychoactive drugs, drug usage, and psychopathology.
Topics: Cannabis; Dose-Response Relationship, Drug; Female; Humans; Lysergic Acid Diethylamide; Male; Mental | 1974 |
[Hallucinogens and psychophopic drugs, their hazards and distribution].
Topics: Amphetamine; Cannabis; Drug and Narcotic Control; Ephedrine; Europe; Germany, West; Hallucinogens; H | 1970 |
The psychology of hallucinogenic drug discontinuers.
Topics: Adult; Anxiety; Depression; Female; Gambling; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mal | 1972 |
The Navajo Indian: A descriptive study of the psychiatric population.
Topics: Adolescent; Adult; Aged; Alcoholism; Arizona; Child; Child, Preschool; Community Mental Health Servi | 1973 |
Navajo peyote use: its apparent safety.
Topics: Adult; Affective Symptoms; Alcoholism; Ceremonial Behavior; Community Mental Health Services; Commun | 1971 |
Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state.
Topics: Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychoanalytic Therapy; Psychoses, | 1969 |
The role of mescaline and D-lysergic acid in psychiatric treatment.
Topics: Environment; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Psychotherapy | 1966 |